Atlas Trials

Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients

Clinical trial NCT03969017 · UNKNOWN

Trial details

NCT number
NCT03969017
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Cirrhosis of Liver Due to Hepatitis B (Disorder)
Start date
2019-06-17
Primary completion
2022-05-30
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.